Recall Enforment Report D-0801-2021

Drug Recall Enforcement Report Class III voluntary initiated by Meitheal Pharmaceuticals Inc, originally initiated on 09-03-2021 for the product Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21 The product was recalled due to failed impurities/degradation specifications. The product was distributed nationwide and the recall is currently ongoing.

Field Name Field Value
Event ID 88619 What is the Event ID?
A numerical designation assigned by FDA to a specific recall event (used for tracking purposes).
Recall Number D-0801-2021 What is the Recall Number?
An alphanumeric designation assigned by FDA to a specific, classified recalled product (used for tracking purposes).
Recall Classification Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences. What is the Recall Classification?
Numerical designation (I, II, or III) that is assigned by FDA to a particular product recall that indicates the relative degree of health hazard. For recalls pending classification, the entry will display as "Not Yet Classified".
Distribution Pattern Nationwide within the USA and India What is the Distribution Pattern?
General area of initial distribution such as states, countries, or territories. Note that subsequent distribution by the consignees to other parties may not be included.
Product Description Glycopyrrolate Injection, USP 4mg per 20mL, 20 mL Multi-Dose Vials, Rx only, Mfd for Meitheal Pharmaceuticals, Chicago, IL 60631. NDC 71288-408-21
Reason For Recall Failed Impurities/Degradation Specifications What is the Reason for Recall?
Information describing how the product is defective.
Product Quantity 1,160 ten-pack cartons Product Quantity
The amount of product subject to recall.
Voluntary Mandated Voluntary: Firm initiated Voluntary / Mandated
Designates that a recall was initiated voluntarily by a firm on its own volition or after being requested to recall by FDA. “Mandatory” designates that a recall was initiated under a mandatory (statutory) recall authority, a court order, or FDA order.
Report Date 09-22-2021
Recall Initiation Date 09-03-2021 What is the Recall Initiation Date?
The date that the firm first began notifying the public or their consignees of the recall.
Initial Firm Notification Letter Initial Firm Notification of Consignee or Public
The method(s) by which the firm initially notified the public or their consignees of a recall.
Product Type Drugs
Recalling Firm Meitheal Pharmaceuticals Inc
Code Info Lot #: G0010120, Exp. Date December 2021; G0080520, Exp. Date April 2022; G0090221, G0100221, Exp. Date January 2023 Code Information
A list of all lot and/or serial numbers, product numbers, expiration dates, sell or use by dates, etc., which appear on the product or its labeling.
Recalled NDC Packages 71288-407-01; 71288-407-03; 71288-407-02; 71288-407-04; 71288-408-05; 71288-408-06; 71288-408-20; 71288-408-21
Status Ongoing

Recalled Products

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Product Type
71288-407Glycopyrrolate GlycopyrrolateInjectionIntramuscular; IntravenousMeitheal Pharmaceuticals Inc.Human Prescription Drug
71288-408Glycopyrrolate GlycopyrrolateInjectionIntramuscular; IntravenousMeitheal Pharmaceuticals Inc.Human Prescription Drug